Can-Fite completes development of biomarker blood test for company's drugs March 20, 2015 No Comments
Merrimack uses RNAscope to select patients for phase II NSCLC trial of MM-121 March 11, 2015 No Comments
Multiplatform tumor profiling shows potential for therapeutic decision-making March 4, 2015 No Comments
RSS